Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate, NASOX HAIC, and PD-1 Inhibitor for Liver Metastases From Pancreatic Cancer
NCT07504471Phase 2Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Implantable Devices, Transdermal Patches, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of sodium bicarbonate ringer's solution, oxaliplatin, nanoliposomal irinotecan, tegafur in pancreatic cancer (PC), sponsored by Ruijin Hospital. Started Mar 2026; status: recruiting.
02
Drugs
sodium bicarbonate ringer's solutionoxaliplatinnanoliposomal irinotecantegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07504471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07504471.